U.S. Congress legislation · 119th Congress
HB10272: End Gas Station Heroin Act
Status: In committee, September 3, 2026
To amend the Controlled Substances Act to schedule MGM-15 and MGM-16 as Schedule I Controlled substances, and to amend the controlled Substances Act to schedule synthetic 7-hydroxymitragynine, and Mitragynine Pseudoindoxyl, as a Schedule I above a specific threshold under the Controlled Substances Act, and to expand enforcement actions against drug manufacturers and distributors of emerging synthetic opioids, commonly known as gas station heroin.
What the bill says
To amend the Controlled Substances Act to schedule MGM-15 and MGM-16 as Schedule I Controlled substances, and to amend the controlled Substances Act to schedule synthetic 7-hydroxymitragynine, and Mitragynine Pseudoindoxyl, as a Schedule I above a specific threshold under the Controlled Substances Act, and to expand enforcement actions against drug manufacturers and distributors of emerging synthetic opioids, commonly known as gas station heroin.
From the introduced text, September 3, 2026:
A BILL To amend the Controlled Substances Act to schedule MGM-15 and MGM-16 as Schedule I Controlled substances, and to amend the controlled Substances Act to schedule synthetic 7-hydroxymitragynine, and Mitragynine Pseudoindoxyl, as a Schedule I above a specific threshold under the Controlled Substances Act, and to expand enforcement actions against drug manufacturers and distributors of emerging synthetic opioids, commonly known as gas station heroin. SECTION 1. Short title This Act may be cited as the End Gas Station Heroin Act . SECTION 2. Scheduling of 7-hydroxymitragynine and mitragynine pseudoindoxyl Schedule I of section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812(c) ) is amended, in subsection (b), by adding at the end the following: (23) (A) 7-hydroxymitragynine (7-OH) and mitragynine pseudoindoxyl, including their salts, isomers, salts of isomers, esters, ethers, and synthetic analogs, whenever the existence of such forms is possible. (B) This paragraph shall not apply to 7-hydroxymitragynine or mitragynine pseudoindoxyl naturally occurring in Mitragyna speciosa Korth (kratom) or in a finished kratom product, provided that-- (i) in the case of a solid, powdered, or encapsulated product, the concentration of 7-hydroxymitragynine and mitragynine pseudoindoxyl, individually or in combination, does not exceed 1 milligram per gram of product; (ii) in the case of a liquid product, the concentration of 7-hydroxymitragynine and mitragynine pseudoindoxyl, individually or in combination, …